Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Amgen
(NQ:
AMGN
)
355.30
+5.91 (+1.69%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 17, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
3,706,463
Open
351.89
Bid (Size)
355.75 (360)
Ask (Size)
356.00 (160)
Prev. Close
349.39
Today's Range
349.42 - 356.69
52wk Range
261.43 - 391.29
Shares Outstanding
538,800,000
Dividend Yield
2.84%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
3 Catalysts That Could Send Teva Stock to $40 and Beyond
↗
Today 5:04 EDT
This once-beaten-down pharma stock remains an intriguing turnaround story.
Via
The Motley Fool
2 S&P 500 Stocks Worth Your Attention and 1 We Ignore
April 17, 2026
The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning. Some companies face significant ch...
Via
StockStory
Topics
Stocks
Performance
YTD
+8.4%
+8.4%
1 Month
+1.1%
+1.1%
3 Month
+7.5%
+7.5%
6 Month
+18.9%
+18.9%
1 Year
+28.1%
+28.1%
More News
Read More
2 Dow Jones Stocks with Exciting Potential and 1 Facing Headwinds
April 16, 2026
Via
StockStory
Topics
Stocks
2 Reasons to Like AMGN and 1 to Stay Skeptical
April 15, 2026
Via
StockStory
Topics
Stocks
MedTech Surge and Oncology Resilience Drive Johnson & Johnson to Q1 Earnings Beat
April 14, 2026
Via
MarketMinute
Topics
Bankruptcy
Earnings
Economy
Johnson & Johnson Shatters Expectations in Q1 2026, Raising Full-Year Outlook as Healthcare Giant Pushes Toward $100 Billion Milestone
April 14, 2026
Via
MarketMinute
Topics
Economy
Intellectual Property
The RAS Revolution: A Deep Dive into Revolution Medicines’ Path to Dominance (2026 Report)
April 14, 2026
Via
Finterra
Topics
Economy
Initial Public Offering
Intellectual Property
Amgen’s Subcutaneous TEPEZZA Data Sets New Gold Standard for Thyroid Eye Disease Treatment
April 13, 2026
Via
MarketMinute
The Science of Scale: An In-Depth Look at Regeneron Pharmaceuticals (REGN) in 2026
April 13, 2026
Via
Finterra
Topics
Earnings
Economy
Intellectual Property
Amgen Reclaims the Lead in Thyroid Eye Disease with Superior Subcutaneous TEPEZZA Data
April 09, 2026
Via
MarketMinute
Topics
Intellectual Property
The "Daily Pill" Revolution: Eli Lilly’s Orforglipron Shatters Records with 25% Weight Loss
April 08, 2026
Via
MarketMinute
Martin Capital Dumps $4.5 Million in Robert Half Shares After a Brutal Year for the Staffing Sector
↗
April 07, 2026
Via
The Motley Fool
Topics
Regulatory Compliance
The Great Metabolic Land Grab: Why Viking and Structure Have Become Big Pharma’s 'Irresistible' Targets
April 03, 2026
Via
MarketMinute
Topics
Intellectual Property
Regeneron Pharmaceuticals: The Scientific Juggernaut Navigating a High-Stakes Transformation
April 03, 2026
Via
Finterra
Topics
Economy
Intellectual Property
World Trade
2 Healthcare Dividend Stocks to Buy as the Tech-Heavy Nasdaq Dips Below Correction Territory
↗
April 02, 2026
Via
The Motley Fool
Topics
Economy
Retirement
Stocks
Roivant and Immunovant Solidify Market Leadership as Brepocitinib and FcRn Programs Hit Critical Clinical Milestones
April 02, 2026
Via
MarketMinute
Topics
Intellectual Property
Dow, S&P 500, Nasdaq: From Morning Meltdown to Midday "Meh"
↗
April 02, 2026
Via
The Motley Fool
Topics
Government
Stocks
World Trade
The Trillion-Dollar Treatment: A Deep Dive into Eli Lilly and Company (LLY)
April 02, 2026
Via
Finterra
Topics
Artificial Intelligence
Economy
Intellectual Property
Gilead Sciences Acquires Ouro Medicines for $2.2 Billion to Lead 'Immune Reset' Revolution
March 31, 2026
Via
MarketMinute
This Top ETF Recently Added a Healthy Dose of These High-Yielding Dividend Stocks
↗
March 30, 2026
Via
The Motley Fool
Topics
ETFs
Stocks
Institutional Titans Bet Big on Amgen as Dividend Yield Hits 2.9% Benchmark
March 23, 2026
Via
MarketMinute
Topics
ETFs
Earnings
FDA Approves Protagonist’s ICOTYDE: The Oral Peptide Revolution Hits the Psoriasis Market
March 23, 2026
Via
MarketMinute
Anthropic Is Worth $380 Billion: This Little-Known ETF Could Let You Own a Piece Before It IPOs
↗
March 19, 2026
Via
The Motley Fool
Topics
Artificial Intelligence
ETFs
AbbVie Shares Retreat to Multi-Month Lows Amid Competitive Headwinds and Technical Breakdown
March 18, 2026
Via
MarketMinute
Topics
ETFs
Economy
Intellectual Property
Amgen, GSK Set To Join TrumpRx Offering Deep Prescription Drug Discounts: Report
↗
March 16, 2026
Via
Benzinga
Frequently Asked Questions
Is Amgen publicly traded?
Yes, Amgen is publicly traded.
What exchange does Amgen trade on?
Amgen trades on the Nasdaq Stock Market
What is the ticker symbol for Amgen?
The ticker symbol for Amgen is AMGN on the Nasdaq Stock Market
What is the current price of Amgen?
The current price of Amgen is 355.30
When was Amgen last traded?
The last trade of Amgen was at 04/17/26 04:00 PM ET
What is the market capitalization of Amgen?
The market capitalization of Amgen is 191.44B
How many shares of Amgen are outstanding?
Amgen has 191B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.